General Hospital Saint-John Bruges
Bruges, Belgium
NCT Number: NCT02661412
The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.
This study is active but is not currently recruiting participants.
All sexes
Observational
Bruges, Belgium
Since its introduction in the late 1990s, immediate implant loading concepts (IL) have become a frequent alternative for delayed implant procedures. IL concepts reduce chair time, the number of surgical interventions and pain, and offer instant comfort to the patient. Its reduced treatment time results in obvious socioeconomic advantages. Although there is at present abundant evidence that supports IL, evaluation of long-term biological and mechanical stability outcomes of large patient populations could allow quality improvement and more accurate patient selection. The Departments of Oral and Maxillofacial Surgery and the Department of Dentistry of the General Hospital Saint-John Bruges act as one of the pioneers of IL in Belgium, routinely performing the concept since 2001.
The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: within 6 months post placement of implants
Percentage of people in the study for which implant is still present of the fixture in the oral cavity
Time frame: until a maximum of 15 years of follow-up
Percentage of people in the study for which implant is still present of the fixture in the oral cavity
Time frame: within 6 months post placement of implants
Percentage of people in the study that develop an infection at the site of the implant in the oral cavity
Time frame: until a maximum of 15 years of follow-up
Percentage of people in the study that develop an infection at the site of the implant in the oral cavity
Time frame: within 6 months post placement of implants
correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon
Time frame: until a maximum of 15 years of follow-up
correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon
Time frame: within 6 months post placement of implants
correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon
Time frame: until a maximum of 15 years of follow-up
correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon
Time frame: within 6 months post placement of implants
correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon
Time frame: until a maximum of 15 years of follow-up
correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon
AZ Sint-Jan AV
Other
Acronym: IMLOAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03812276
Jaw Diseases, Jaw, Edentulous
Curitiba, Paraná, Brazil
View Trial DetailsNCT00901017
Jaw Diseases, Jaw, Edentulous
Leuven, Belgium
View Trial DetailsNCT05859113
Jaw Diseases, Jaw, Edentulous
Granada, Spain
View Trial DetailsNCT05315414
Jaw Diseases, Jaw, Edentulous
Iowa City, Iowa, United States
View Trial Details